Ziska Pharmaceuticals Ltd
Ziska Pharmaceuticals Ltd., a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and operates extensively across South Asia and beyond. Founded in 1992, the company has established itself as a leader in the development and manufacturing of high-quality generic medicines, particularly in the fields of anti-infectives, cardiovascular, and central nervous system treatments. Ziska Pharmaceuticals is renowned for its commitment to innovation and quality, offering a diverse portfolio of products that cater to various therapeutic areas. The company’s state-of-the-art manufacturing facilities adhere to international standards, ensuring the delivery of safe and effective medications. With a strong market presence and a reputation for excellence, Ziska Pharmaceuticals continues to make significant strides in improving healthcare outcomes in the regions it serves.
DitchCarbon Score
How does Ziska Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ziska Pharmaceuticals Ltd's score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ziska Pharmaceuticals Ltd's reported carbon emissions
Ziska Pharmaceuticals Ltd, headquartered in Bangladesh (BD), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that Ziska Pharmaceuticals Ltd has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Ziska Pharmaceuticals Ltd may benefit from establishing clear climate commitments and reduction initiatives to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ziska Pharmaceuticals Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
